Metabolic follow-up after long-term pancreas graft survival

European Journal of Endocrinology

Volumn 156, Issue 5, 2007, Pages 603-610

  Dieterle, Christoph D ^a   Arbogast, Helmut ^a   Illner, Wolf Dieter ^a   Schmauss, Susanne ^a   Landgraf, Rüdiger ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; GLUCAGON; GLUCOCORTICOID; GLUCOSE; HEMOGLOBIN A1C; IMMUNOSUPPRESSIVE AGENT; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; GRAFT REJECTION; GRAFT SURVIVAL; HEMOGLOBIN DETERMINATION; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MALE; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GLUCAGON; GLUCOSE TOLERANCE TEST; GRAFT SURVIVAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; PANCREAS TRANSPLANTATION; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 34249021049     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-06-0658     Document Type: Article

References (28)

1. Robertson P, Davis C, Larsen J, Stratta R & Sutherland DE. Pancreas transplantation in type 1 diabetes. Diabetes Care 2004 27 S105.
2. Larsen JL. Pancreas transplantation: indications and consequences. Endocrine Reviews 2004 25 919-946.
3. Landgraf R. Pancreatic transplantation and its future role in diabetes management. Diabetic Medicine 1995 12 947-948.
4. Tyden G, Bolinder J, Solders G, Brattstrom C, Tibell A & Groth CG. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 1999 67 645-648.
5. Smets YF, Westendorp RG, Van Der Pijl JW, De Charro FT, Ringers J, De Fijter JW & Lemkes HH. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999 353 1915-1919.
6. Becker BN, Brazy PC, Becker YT, Odorico JS, Pintar TJ, Collins BH, Pirsch JD, Leverson GE, Heisey DM & Sollinger HW. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney International 2000 57 2129-2135.
7. Ojo a O, Meier-Kriesche HU, Hanson JA, Leichtman A, Magee JC, Cibrik D, Wolfe RA, Port FK, Agodoa L, Kaufman DB & Kaplan B. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001 71 82-90.
8. Gruessner RW, Sutherland DE & Gruessner a C. Mortality assessment for pancreas transplants. American Journal of Transplantation 2004 4 2018-2026.
9. Sutherland DE, Najarian JS, Greenberg BZ, Senske BJ, Anderson GE, Francis RS & Goetz FC. Hormonal and metabolic effects of a pancreatic endocrine graft. Vascularized segmental transplantation in insulin-dependent diabetic patients. Annals of Internal Medicine 1981 95 537-541.
10. Sutherland DE & Gruessner A. Long-term function (> 5 years) of pancreas grafts from the international pancreas transplant registry database. Transplantation Proceedings 1995 27 2977-2980.
11. Lo A, Stratta RJ, Hathaway DK, Egidi MF, Shokouh-Amiri MH, Grewal HP, Winsett R, Trofe J, Alloway RR & Gaber AO. Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage. American Journal of Kidney Diseases 2001 38 132-143.
12. Martin X, Feitosa Tajra LC, Benchaib M, Dawahra M, Lefrancois N & Dubernard JM. Long-term outcome of pancreas transplantation. Transplantation Proceedings 1997 29 2423-2424.
13. Sudan D, Sudan R & Stratta R. Long-term outcome of simultaneous kidney-pancreas transplantation: analysis of 61 patients with more than 5 years follow-up. Transplantation 2000 69 550-555.
14. Alberti KG & Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998 15 539-553.
15. Jensen CC, Cnop M, Hull RL, Fujimoto WY & Kahn SE. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 2002 51 2170-2178.
16. Matthews DR, Hosker JP, Rudenski a S, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
17. Matsuda M & DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 22 1462-1470.
18. Humar A, Gruessner RW & Sutherland DE. Living related donor pancreas and pancreas-kidney transplantation. British Medical Bulletin 1997 53 879-891.
19. Robertson RP. Consequences on beta-cell function and reserve - after long-term pancreas transplantation. Diabetes 2004 53 633-644.
20. Kessler L, Passemard R, Oberholzer J, Benhamou PY, Bucher P, Toso C, Meyer P, Penfornis A, Badet L, Wolf P, Colin C, Morel P & Pinget M. Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring. Diabetes Care 2002 25 2256-2262.
21. Christiansen E, Tibell A, Volund a A, Holst JJ, Rasmussen K, Schaffer L & Madsbad S. Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. Journal of Clinical Endocrinology and Metabolism 1997 82 2299-2307.
22. Pfeffer F. Nauck MA, Drognitz O, Benz S, Von Dobschuetz E & Hopt UT. Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas-kidney transplantation. Transplantation 2003 76 1427-1431.
23. Shim WS, Kim SK, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC & Cha BS. Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes. European Journal of Endocrinology 2006 155 615-622.
24. Weyer C, Bogardus C, Mott DM & Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Journal of Clinical Investigation 1999 104 787-794.
25. Matte J, Fery F, Lankoande C, Schinoboritis P & De Pauw L. Insulin secretion and glucose tolerance evolution in kidney-pancreas graft. Transplantation Proceedings 1995 27 3073-3074.
26. Marco J, Diego J, Villanueva ML, Diaz-Fierros M, Valverde I & Segovia JM. Elevated plasma glucagon levels in cirrhosis of the liver. New England Journal of Medicine 1973 289 1107-1111.
27. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J & Gerich J. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. New England Journal of Medicine 1992 326 22-29.
28. Drucker DJ & Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006 368 1696-1705.